Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

LivaNova PLC Regulatory Filings 2021

Mar 1, 2021

31419_rns_2021-03-01_a65531d1-36a9-475d-ac3e-b1ea991f6bf2.zip

Regulatory Filings

Open in viewer

Opens in your device viewer

IRANNOTICE 1 livn-20201231xirannotice.htm IRANNOTICE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd" Document created using Wdesk Copyright 2021 Workiva Document

U.S. Securities and Exchange Commission

100 F Street N.E.

Washington, D.C. 20549

March 1, 2021

Re: Notice of Disclosure Filed in Exchange Act Quarterly Report under Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 and Section 13(r) of the Securities Exchange Act of 1934

Ladies and Gentlemen:

Pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 and Section 13(r) of the Securities Exchange Act of 1934, as amended, notice is hereby provided that LivaNova PLC has made disclosure pursuant to those provisions in its Annual Report on Form 10-K for the period ended December 31, 2020, which was filed with the Securities and Exchange Commission on March 1, 2021. The disclosure can be found within Part I, Item 1. Business in the Annual Report on Form 10-K.

Respectfully submitted,

LivaNova PLC

By:
Damien McDonald
Chief Executive Officer
By:
Alex Shvartsburg
Chief Financial Officer